Is Single-Night Home Sleep Testing Failing Your Patients? Multi-night home sleep testing with EnsoSleep PPG™ boosts diagnostic accuracy, reduces hardware costs, and results in better patient outcomes
The new, powerful, accessible, non-invasive PPG signal form factors allow for newer screening, testing, and monitoring devices that cost less than traditional options, while maintaining similar clinical quality.
For EnsoData, 2024 was a year full of exciting initiatives and announcements. Explore the most engaging EnsoData content from the past year.
Aeroflow partnered with EnsoData to integrate EnsoTherapy into their sleep coaching workflow. EnsoTherapy is an AI solution that predicts 90-day therapy adherence within days of sleep apnea patients starting treatment. This helps improve PAP adherence rates across their patient population by more than 100%.
In sleep medicine, data tells the story. The more data you have, the more complete the story. And sometimes, looking at the same raw data in new ways results in new, advanced metrics. With EnsoSleep Study Management, we are constantly upgrading the available metrics, which now includes Hypoxic Burden information.
Read our blog for insight and feedback from four sleep technologists on EnsoSleep Scoring Certification.
Clinical expertise, quality customer support, and high-tech, home-grown solutions are just a few things to love about EnsoData.
Dive into this SLEEP 2024 Recap post for all the highlights, innovations, and insights from this year’s biggest sleep medicine conference.
Aeroflow and EnsoData usher in a new era in personalized sleep apnea care, population health management, and patient coaching with AI-powered predictive analysis of CPAP monitoring data.